EWTX EPS Estimates
Edgewise Therapeutics, Inc.
$37.02
+$0.74(+2.04%)
41
Overall
60
Value
30
Tech
34
Quality
Market Cap
$4.02B
Volume
1.45M
52W Range
$14.25 - $48.51
Target Price
$52.62
EWTX EPS estimates: the consensus estimate for Edgewise Therapeutics, Inc.'s current fiscal year is -$2.09 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
EWTX EPS Estimates
- EPS estimate, current quarter
- $-0.55
- EPS estimate, next quarter
- $-0.53
- EPS estimate, current year
- $-2.09
- EPS estimate, next year
- $-1.80
- EPS growth, 3-year
- -8.96%
| Fiscal year | EPS |
|---|---|
| 2025 | $-1.63 |
| 2024 | $-1.45 |
| 2023 | $-1.57 |
| 2022 | $-1.26 |
| 2021 | $-1.14 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | EWTX | $37.02 | +2.0% | 1.45M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Edgewise Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW